Top Varicose Veins Treatment Companies

Global Varicose Veins Treatment Market size was valued at USD 1.39 Billion in 2024 and is poised to grow from USD 1.48 Billion in 2025 to USD 2.49 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026–2033).

The global varicose veins treatment market is characterized by a competitive landscape with several players striving to capture a significant market share. These market participants include manufacturers, healthcare providers, research institutions, and other stakeholders involved in the development, production, and distribution of varicose veins treatment solutions. The competition in the market is driven by factors such as product efficacy, safety, innovation, pricing strategies, and geographic presence. Companies in the market focus on developing and launching technologically advanced treatment options to meet the growing demand for minimally invasive procedures. Research and development efforts are directed towards enhancing the effectiveness of existing treatments and exploring novel therapeutic approaches. 'Medtronic plc (Ireland) ', 'AngioDynamics, Inc. (USA ', 'Teleflex Incorporated (USA ', 'Boston Scientific Corporation (USA) ', 'Lumenis Ltd. (Israel) ', 'Quanta System S.p.A. (Italy) ', 'Biolitec AG (Austria) ', 'Dornier MedTech GmbH (Germany) ', 'Sciton, Inc. (USA) ', 'Fotona d.o.o. (Slovenia) ', 'Viatris Inc. (USA) ', 'Merz Aesthetics (USA) ', 'SIGVARIS Group (Switzerland) ', 'Essity Aktiebolag (publ) (Sweden) ', 'F Care Systems NV (Belgium) ', 'VVT Medical (Israel) ', 'Alma Lasers (Israel) ', 'Energist Group (UK). ', 'Eufoton s.r.l. (Italy) ', 'WONTECH Co., Ltd. (South Korea)'

Increased awareness and education regarding varicose veins and available treatment options have contributed to market growth. Public awareness campaigns, patient education initiatives, and information dissemination through various channels have encouraged individuals with varicose veins to seek appropriate treatment.

Growing Emphasis on Combination Therapies: Combination therapies involving multiple treatment modalities are gaining popularity in varicose veins treatment. Combining procedures such as endovenous ablation and sclerotherapy can optimize outcomes by targeting different aspects of the venous disease, leading to improved efficacy and patient satisfaction.

North America emerged as the dominant market, accounting for a revenue share. This can be attributed to a significant patient base in the region, with a strong emphasis on aesthetics. People in North America are increasingly willing to undergo cosmetic procedures due to the noticeable results and perceived safety. Laser treatments, in particular, have played a significant role in reducing the stigma associated with cosmetic procedures and gaining social acceptance, especially among men. The demonstrated safety and efficacy of laser procedures have contributed to their popularity in the region.